Aims and scope
JARO shares similar principles and core values as ARO, by promoting rigorous science, embracing diversity, inspiring integrity, encouraging collaboration, and supporting education. It is a peer-reviewed journal dedicated to disseminating research focusing on the auditory and vestibular systems.
Our goals are:
* to attract and publish the best research and the most thought-provoking opinions about hearing and balance;
* to serve as a platform for meaningful debates on scientific, clinical, and public health matters within the field of otolaryngology;
* to further the interests of the auditory and vestibular research community both in Europe and worldwide;
* and to facilitate the translation of scientific advancements into tangible clinical benefits for individuals facing challenges related to hearing loss, communication, and vestibular disorders.
JARO welcomes submissions describing original experimental research that investigates the mechanisms underlying problems of basic or clinical significance. Example of research areas include (but are not only restricted to): molecular biology and development, genetics related to hearing and balance mechanisms, biochemistry, cochlear anatomy and physiology, mechanotransduction and cochlear mechanics, vestibular anatomy and physiology, ototoxicity, electrophysiology, opto- and chemo-genetics, middle ear anatomy and modeling, computational central anatomy, behavior and physiology, psychoacoustics in normal and hearing-impaired subjects, midbrain and central plasticity, tinnitus and hyperacusis, and studies of hearing perception in cochlear implant patients.
JARO is open to submissions describing original experimental research that advances our understanding of issues with both basic and clinical significance in the field of auditory and vestibular systems. Topics of interest are for instance presented at the Annual ARO Mid-Winter Meeting. ARO is the world’s largest organization of hearing and balance researchers.
Manuscripts on surgical procedures or head and neck cancers, are typically not considered.